Written by OneGuild

At OneGuild, we believe scientific progress must be inclusive, future-focused, and deeply human. The Peter Sheehan Young Innovator Award reflects this vision — honoring early-career scientists whose research is pushing the boundaries of what’s possible in tissue regeneration, clinical diagnostics, therapeutics, and diabetic limb preservation.

Created as part of the legacy of Dr. Peter Sheehan, the award recognizes pioneering research with the potential to advance scientific discovery, clinical practice, and industry innovation — including pathways toward real-world application and commercialization. It reflects Dr. Sheehan’s belief that true innovation in diabetes care requires not only scientific excellence, but also translation, collaboration, and vision.

Each year, the award aims to spotlight breakthrough research that addresses urgent challenges in limb preservation and the prevention of diabetes-related amputations — critical areas of need affecting millions worldwide.

But our ambition doesn’t stop there.

We are working to expand the award’s reach, particularly to individuals in low- and middle-income countries, where promising ideas and innovations often go unseen or unsupported. Whether rooted in research, practice, or lived experience, these contributions matter. Building bridges, removing barriers, and surfacing this kind of work is central to OneGuild’s broader mission.

Looking ahead, we hope to grow the award’s scope to include a wider range of diabetes-related complications — and to build the partnerships needed to support young innovators more powerfully, wherever they are.

The Peter Sheehan Young Innovator Award is a call to dream forward. And it’s just the beginning.